Related Experiment Video

Updated: May 13, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer

Jiarui Li1, Zhang Ping, Hui Ning

  • 1Department of Gynecology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China. huining_nj@yeah.net.

International Journal of Molecular Sciences
|February 28, 2013
PubMed

Insights

MicroRNA-218 (miR-218) inhibits cervical cancer cell growth and metastasis by regulating the AKT-mTOR pathway. Targeting miR-218 shows potential for blocking cervical cancer development and improving chemotherapy sensitivity.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs regulate gene expression post-transcriptionally.
  • miR-218 is implicated in tumor metastasis.
  • Cervical cancer remains a significant global health concern.

Purpose of the Study:

  • To investigate the role and regulation of miR-218 in cervical cancer.
  • To elucidate the molecular mechanisms underlying miR-218's function in cervical cancer.

Main Methods:

  • Overexpression of miR-218 in HeLa cervical cancer cells.
  • Assessment of cell proliferation and apoptosis.
  • Analysis of the AKT-mTOR signaling pathway.
  • In vivo studies using an orthotopic mouse model.
  • Evaluation of chemosensitivity to cisplatin (CDDP).

Main Results:

  • Overexpression of miR-218 reduced HeLa cell proliferation and induced apoptosis via the AKT-mTOR pathway.
  • Forced miR-218 expression suppressed tumor growth in vivo.
  • miR-218 enhanced sensitivity to cisplatin in vitro.

Conclusions:

  • miR-218 acts as a tumor suppressor in cervical cancer.
  • Targeting miR-218 may offer a therapeutic strategy for cervical cancer.
  • miR-218 modulation can improve treatment outcomes, including chemotherapy response.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...